MedTrace Logo

SPECT/CT Prospective Double-Scanning Study

NCT07725237 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-07-24

No results posted yet for this study

Summary

The goal of this study is to collect image data for StarGuide GX SPECT/CT System in a clinical setting. The StarGuide GX scan will be compared to the participant's clinically indicated SPECT/CT scanner. Participants will be adult patients scheduled to undergo a clinically indicated SPECT/CT.

Conditions

  • SPECT-CT

Interventions

DEVICE

StarGuide GX SPECT/CT Scan

Participants will undergo two SPECT/CT scans and will be randomized to determine whether imaging with the StarGuide GX scanner or the commercially released reference scanner is performed first. The second scan will begin within one hour of completion of the first scan. No additional tracer will be administered prior to the second imaging session, as both scans will utilize the initially administered dose. Following completion of both scans, participants will be asked to complete a brief questionnaire.

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER

  • GE Healthcare

    lead INDUSTRY

Principal Investigators

  • Brian Thomsen · GE Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-02-28
Completion
2027-02-28
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07725237 on ClinicalTrials.gov